Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant etoposide and cisplatin chemotherapy in patients with unresectable stage III non-small-cell carcinoma of the lung

J Natl Cancer Inst. 1993 Feb 17;85(4):321-3. doi: 10.1093/jnci/85.4.321.

Authors

E G Shaw¹, W L McGinnis, J R Jett, J Q Su, A R Frank, J A Mailliard, R E Engel, M Wiesenfeld, K M Rowland Jr

Affiliation

¹ Division of Radiation Oncology, Mayo Clinic, MN 55905.

PMID: 8381189
DOI: 10.1093/jnci/85.4.321

No abstract available

Publication types

Clinical Trial
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma, Non-Small-Cell Lung / drug therapy
Carcinoma, Non-Small-Cell Lung / radiotherapy
Carcinoma, Non-Small-Cell Lung / therapy*
Cisplatin / therapeutic use
Combined Modality Therapy
Etoposide / therapeutic use
Female
Humans
Lung Neoplasms / drug therapy
Lung Neoplasms / radiotherapy
Lung Neoplasms / therapy*
Male
Middle Aged
Pilot Projects
Radiotherapy Dosage

Substances

Etoposide
Cisplatin